SCHEMBL774116

SCHEMBL774116

C=C(C)C1CCC(C)CC1

nearest known ligand 0.37

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
ALDH1A1 P00352 2/20 0.33
ALOX15 P16050 1/20 0.33
CYP1B1 Q16678 1/20 0.33
TSHR P16473 2/20 0.32
TRPA1 O75762 1/20 0.32
TP53 P04637 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17632024 1.00 LMNA (0.37) LMNAALDH1A1ALOX15CYP1B1TSHR
SCHEMBL11103446 0.87 LMNA (0.42) LMNAALDH1A1ALOX15CYP1B1TSHR
SCHEMBL9129884 0.87
SCHEMBL513994 0.87
SCHEMBL4929480 0.86 LMNA (0.31) LMNATSHRTRPA1
SCHEMBL7460275 0.83
SCHEMBL26137767 0.83
SCHEMBL15051866 0.78
SCHEMBL3934132 0.77 ALDH1A1 (0.38) LMNAALDH1A1ALOX15CYP1B1TSHR
SCHEMBL8486246 0.77 LMNA (0.37) LMNAALDH1A1ALOX15CYP1B1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109668767-B Special dewaxing liquid for blood coagulation tissues and preparation method thereof 黄杰 2021-07-20 CN claimed
EP-3197510-A1 DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS The Procter & Gamble Company (US) 2017-08-02 EP claimed
WO-2016049407-A1 ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049458-A1 DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-20130216723-A1 SULFONATE ESTERS AS LATENT ACID CATALYSTS KING INDUSTRIES (US) 2013-08-22 US claimed
EP-2203519-A1 SULFONATE ESTERS AS LATENT ACID CATALYSTS King Industries (US) 2010-07-07 EP claimed
CN-101629067-A Natural solvent used for producing spray LIJIE HUANG 2010-01-20 CN claimed
US-20090104363-A1 Sulfonate esters as latent acid catalysts KING INDUSTRIES 2009-04-23 US claimed
WO-2009045466-A1 SULFONATE ESTERS AS LATENT ACID CATALYSTS KING INDUSTRIES (US) 2009-04-09 WO claimed
US-20080200738-A1 PYROLYTIC PROCESS AND APPARATUS FOR PRODUCING ENHANCED AMOUNTS OF AROMATC COMPOUNDS POLYFLOW CORPORATION (US) 2008-08-21 US claimed
US-20050211274-A1 Heat exchanger cleaning process REFINED TECHNOLOGIES, INC. 2005-09-29 US claimed
US-6936112-B2 Heat exchanger cleaning process REFINED TECHNOLOGIES, INC. (US) 2005-08-30 US claimed
US-20040102351-A1 Heat exchanger cleaning process REFINED TECHNOLOGIES, INC. 2004-05-27 US claimed
EP-0947572-B1 Heat transfer fluid compositions for low temperature applications LOIKITS IND SERVICES (US) 2003-11-26 EP claimed
US-6086782-A MIXTURE OF TERPENE AND ALKYLBENZENE ADVANCED FLUID TECHNOLOGIES, INC. (US) 2000-07-11 US claimed
EP-0947572-A1 Heat transfer fluid compositions for low temperature applications Loikits Industrial Services (US) 1999-10-06 EP claimed
US-5847246-A Fluid heat transfer medium and heat transfer process Loikits, Daniel J. (US) 1998-12-08 US claimed
WO-1997008116-A1 FLUID HEAT TRANSFER MEDIUM AND HEAT TRANSFER PROCESS LOIKITS INDUSTRIAL SERVICES (US) 1997-03-06 WO claimed
US-4980485-A Method of manufacturing optically-active periplanone-b JAPAN TOBACCO INC. (JP) 1990-12-25 US claimed
US-4623687-A Bicyclic phosphine oxides and their use as flame retardants in styrene modified polyphenylene ether resins FMC CORPORATION (US) 1986-11-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104363-A1 Sulfonate esters as latent acid catalysts ORAI1, SARAF, NAPA LMNA 306/4885ALDH1A1 3647/4885ALOX15 787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.